Does VEDOLIZUMAB Cause Female genital tract fistula? 247 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Female genital tract fistula have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.3% of all adverse event reports for VEDOLIZUMAB.
247
Reports of Female genital tract fistula with VEDOLIZUMAB
0.3%
of all VEDOLIZUMAB reports
0
Deaths
165
Hospitalizations
How Dangerous Is Female genital tract fistula From VEDOLIZUMAB?
Of the 247 reports, 165 (66.8%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Female genital tract fistula Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 247 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Female genital tract fistula?
ADALIMUMAB (437)
METRONIDAZOLE (254)
INFLIXIMAB (237)
ACETAMINOPHEN (235)
PREDNISONE (231)
HYDROCORTISONE (229)
FLUTICASONE (227)
HYDROMORPHONE (227)
CLARITHROMYCIN (225)
MESALAMINE (223)
Which VEDOLIZUMAB Alternatives Have Lower Female genital tract fistula Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB